Bibliografie
1. Hoberman JM, Yesalis CE. The history of synthetic testosterone. Sci Am. 1995 Feb;272(2):76-81
2. Freeman ER, Bloom DA, McGuire EJ. A brief history of testosterone. J Urol. 2001 Feb;165(2):371-3
3. Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem. 1997 Jul;43(7):1262-79
4. Berning JM, Adams KJ, Stamford BA. Anabolic steroid usage in athletics: facts, fiction, and public relations. J Strength Cond Res. 2004 Nov;18(4):908-17
5. Gardner DG, Shoback D. Greenspan’s Basic & Clinical Endocrinology, eight edition. McGraw-Hill, 2007
6. Kronenberg HM, Melmed S, Polonsky KS, Reed Larsen P. Williams Textbook of Endocrinology, eleven edition. Saunders, 2007
7. Blue JG, Lombardo JA. Steroids and steroid-like compounds. Clin Sports Med. 1999 Jul;18(3):667-89, ix
8. Elashoff JD, Jacknow AD, Shain SG, Braunstein GD. Effects of anabolic-androgenic steroids on muscular strength. Ann Intern Med. 1991 Sep 1;115(5):387-93
9. Hickson RC, Czerwinski SM, Falduto MT, Young AP. Glucocorticoid antagonism by exercise and androgenic-anabolic steroids. Med Sci Sports Exerc. 1990 Jun;22(3):331-40
10. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF, Bhasin S. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology. 2003 Nov;144(11):5081-8
11. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A, Casaburi R. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996 Jul 4;335(1):1-7
12. Storer TW, Magliano L, Woodhouse L, Lee ML, Dzekov C, Dzekov J, Casaburi R, Bhasin S. Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab. 2003 Apr;88(4):1478-85
13. Hershberger LG, Shipley EG, Meyer RK. Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method. Proc Soc Exp Biol Med. 1953 May;83(1):175-80
14. Chrousos GP. The gonadal hormones and inhibitors. In Katzung BG (ed.), Basic and Clinical Pharmacology. McGraw-Hill, 2006, pp. 674-6
15. Basaria S, Wahlstrom JT, Dobs AS. Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab. 2001 Nov;86(11):5108-17
16. Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, Klibanski A. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1998 Jul 1;129(1):18-26
17. Gascón A, Belvis JJ, Berisa F, Iglesias E, Estopiñán V, Teruel JL. Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis. Geriatr Nephrol Urol. 1999;9(2):67-72
18. Chesnut CH 3rd, Ivey JL, Gruber HE, Matthews M, Nelp WB, Sisom K, Baylink DJ. Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. Metabolism. 1983 Jun;32(6):571-80
19. Need AG, Nordin BE, Chatterton BE. Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate. Osteoporos Int. 1993;3 Suppl 1:218-22
20. Sullivan ML, Martinez CM, Gennis P, Gallagher EJ. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis. 1998 Jul-Aug;41(1):1-15
21. Melchert RB, Welder AA. Cardiovascular effects of androgenic-anabolic steroids. Med Sci Sports Exerc. 1995 Sep;27(9):1252-62
22. Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, Lenzi A, Fabbri A. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf). 2005 Sep;63(3):280-93
23. Coviello AD, Kaplan B, Lakshman KM, Chen T, Singh AB, Bhasin S. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab. 2008 Mar;93(3):914-9
24. Bronson FH, Matherne CM. Exposure to anabolic-androgenic steroids shortens life span of male mice. Med Sci Sports Exerc. 1997 May;29(5):615-9
25. Pärssinen M, Kujala U, Vartiainen E, Sarna S, Seppälä T. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med. 2000 Apr;21(3):225-7
26. Ishak KG, Zimmerman HJ. Hepatotoxic effects of the anabolic/androgenic steroids. Semin Liver Dis. 1987 Aug;7(3):230-6
27. Sweeney EC, Evans DJ. Hepatic lesions in patients treated with synthetic anabolic steriods. J Clin Pathol. 1976 Jul;29(7):626-33
28. Bahrke MS, Yesalis CE 3rd, Wright JE. Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. An update. Sports Med. 1996 Dec;22(6):367-90
29. Pope HG Jr, Kouri EM, Hudson JI. Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry. 2000 Feb;57(2):133-40
30. Vogel W, Klaiber EL, Broverman DM. A comparison of the antidepressant effects of a synthetic androgen (mesterolone) and amitriptyline in depressed men. J Clin Psychiatry. 1985 Jan;46(1):6-8
31. Wilson IC, Prange AJ Jr, Lara PP. Methyltestosterone with imipramine in men: conversion of depression to paranoid reaction. Am J Psychiatry. 1974 Jan;131(1):21-4
32. Cohen JC, Hickman R. Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids. J Clin Endocrinol Metab. 1987 May;64(5):960-3
33. Deyssig R, Weissel M. Ingestion of androgenic-anabolic steroids induces mild thyroidal impairment in male body builders. J Clin Endocrinol Metab. 1993 Apr;76(4):1069-71
34. Barbosa J, Seal US, Doe RP. Effects of anabolic steroids on hormone-binding proteins, serum cortisol and serum nonprotein-bound cortisol. J Clin Endocrinol Metab. 1971 Feb;32(2):232-40
35. Sinnecker G, Köhler S. Sex hormone-binding globulin response to the anabolic steroid stanozolol: evidence for its suitability as a biological androgen sensitivity test. J Clin Endocrinol Metab. 1989 Jun;68(6):1195-200
36. Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc. 2006 Apr;38(4):644-51
37. Verroken M. Ethical aspects and the prevalence of hormone abuse in sport. J Endocrinol. 2001 Jul;170(1):49-54
38. Gruber AJ, Pope HG Jr. Compulsive weight lifting and anabolic drug abuse among women rape victims. Compr Psychiatry. 1999 Jul-Aug;40(4):273-7
39. Middleman AB, Faulkner AH, Woods ER, Emans SJ, DuRant RH. High-risk behaviors among high school students in Massachusetts who use anabolic steroids. Pediatrics. 1995 Aug;96(2 Pt 1):268-72
40. Yesalis CE, Kennedy NJ, Kopstein AN, Bahrke MS. Anabolic-androgenic steroid use in the United States. JAMA. 1993 Sep 8;270(10):1217-21
41. Brower KJ. Withdrawal from anabolic steroids. Curr Ther Endocrinol Metab. 1997;6:338-43
42. Kashkin KB, Kleber HD. Hooked on hormones? An anabolic steroid addiction hypothesis. JAMA. 1989 Dec 8;262(22):3166-70
43. Basaria S. Androgen abuse in athletes: detection and consequences. J Clin Endocrinol Metab. 2010 Apr;95(4):1533-43
44. Holma PK. Effects of an anabolic steroid (metandienone) on spermatogenesis. Contraception. 1977 Feb;15(2):151-62
45. Knuth UA, Maniera H, Nieschlag E. Anabolic steroids and semen parameters in bodybuilders. Fertil Steril. 1989 Dec;52(6):1041-7
46. Drakeley A, Gazvani R, Lewis-Jones I. Duration of azoospermia following anabolic steroids. Fertil Steril. 2004 Jan;81(1):226
47. Turek PJ, Williams RH, Gilbaugh JH 3rd, Lipshultz LI. The reversibility of anabolic steroid-induced azoospermia. J Urol. 1995 May;153(5):1628-30
48. Gazvani MR, Buckett W, Luckas MJ, Aird IA, Hipkin LJ, Lewis-Jones DI. Conservative management of azoospermia following steroid abuse. Hum Reprod.
1997 Aug;12(8):1706-8
49. Martikainen H, Alén M, Rahkila P, Vihko R. Testicular responsiveness to human chorionic gonadotrophin during transient hypogonadotrophic hypogonadism induced by androgenic/anabolic steroids in power athletes. J Steroid Biochem. 1986 Jul;25(1):109-12